Joshua D Grill (Joshua Grill)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 13

Top Topics

Psychometric Properties

Cognitive Impairment

Top Venues

Neurology. Clinical practice

Alzheimer's research & therapy

Clinical trials (London, England)

Annals of neurology

This page only lists publications with an associated author ORCID identifier.

Publications

Joshua D Grill, Rema Raman, Karin Ernstrom, Shunran Wang, Michael C Donohue, Paul S Aisen, Jason Karlawish, David Henley, Gary Romano, Gerald Novak, H Robert Brashear, Reisa A Sperling
Immediate Reactions to Alzheimer Biomarker Disclosure in Cognitively Unimpaired Individuals in a Global Truncated Randomized Trial. Neurology. Clinical practice 14 (2) (2024)
Marina Ritchie, Seyed Ahmad Sajjadi, Joshua D Grill
Apolipoprotein E Genetic Testing in a New Age of Alzheimer Disease Clinical Practice. Neurology. Clinical practice 14 (2) (2024)
Marina Ritchie, Seyed Ahmad Sajjadi, Joshua D Grill
Apolipoprotein E Genetic Testing in a New Age of Alzheimer Disease Clinical Practice. Neurology. Clinical practice 14 (2) (2024)
Joshua D Grill, Rema Raman, Karin Ernstrom, Shunran Wang, Michael C Donohue, Paul S Aisen, Jason Karlawish, David Henley, Gary Romano, Gerald Novak, H Robert Brashear, Reisa A Sperling
Immediate Reactions to Alzheimer Biomarker Disclosure in Cognitively Unimpaired Individuals in a Global Truncated Randomized Trial. Neurology. Clinical practice 14 (2) (2024)
Joshua D Grill, Rema Raman, Karin Ernstrom, Shunran Wang, Michael C Donohue, Paul S Aisen, Jason Karlawish, David Henley, Gary Romano, Gerald Novak, H Robert Brashear, Reisa A Sperling
Immediate Reactions to Alzheimer Biomarker Disclosure in Cognitively Unimpaired Individuals in a Global Truncated Randomized Trial. Neurology. Clinical practice 14 (2) (2024)
Joshua D Grill, Charlene Flournoy, Shobha Dhadda, Karin Ernstrom, Reisa Sperling, Doris Molina Henry, Kate Tranotti, Russell Harris, Michio Kanekiyo, Michelle Gee, Michael Irizarry, Lynn Kramer, Paul Aisen, Rema Raman
Eligibility rates among racially and ethnically diverse US participants in Phase 2 and Phase 3 placebo-controlled, double-blind, randomized trials of lecanemab and elenbecestat in early Alzheimer's disease. Annals of neurology (2023)
Emily A Largent, Joshua D Grill, Kyra O'Brien, David Wolk, Kristin Harkins, Jason Karlawish
Testing for Alzheimer Disease Biomarkers and Disclosing Results Across the Disease Continuum. Neurology (2023)
Shana D Stites, R Scott Turner, Jeanine Gill, Anna Gurian, Jason Karlawish, Joshua D Grill, null null
Research Attitudes Questionnaire scores predict Alzheimer's disease clinical trial dropout. Clinical trials (London, England) 18 (2) (2021)
Michelle M Nuño, Joshua D Grill, Daniel L Gillen, null null
On the design of early-phase Alzheimer's disease clinical trials with cerebrospinal fluid tau outcomes. Clinical trials (London, England) 18 (6) (2021)
Joshua D Grill, Chelsea G Cox, Kristin Harkins, Jason Karlawish
Response to "Avoiding Methodological Bias in Studies of Amyloid Imaging Results Disclosure". Alzheimer's research & therapy 11 (1) (2019)
Mary M Ryan, Joshua D Grill, Daniel L Gillen, null null
Participant and study partner prediction and identification of cognitive impairment in preclinical Alzheimer's disease: study partner vs. participant accuracy. Alzheimer's research & therapy 11 (1) (2019)
Joshua D Grill, Chelsea G Cox, Kristin Harkins, Jason Karlawish
Reactions to learning a "not elevated" amyloid PET result in a preclinical Alzheimer's disease trial. Alzheimer's research & therapy 10 (1) (2018)
Joshua D Grill, Jason Karlawish
Study partners should be required in preclinical Alzheimer's disease trials. Alzheimer's research & therapy 9 (1) (2017)